Angelini Pharma Enters Into An Exclusive Option Agreement With Cureverse to License Global Development and Commercialization Rights For A Novel and Innovative Clinical-Stage Brain Health Asset 21-10-2024, 11:00

New Survey Shows Shoppers Are Showing Up This Holiday Season — Even Amid Tariffs and Turmoil 17-07-2025, 19:00

Animoca Brands and AlphaTON Capital announce equity and token investments; AlphaTON intends to acquire GAMEE 1-10-2025, 08:35